Visualizing Drug Discovery and Development

Visualizing Drug Discovery & Development – Networking & Seminar Afternoon

Join Miltenyi Biotec at BioInnovation Institute for an afternoon of insights and networking focused on cutting-edge imaging techniques in drug discovery and development.

Discover how 3D imaging and multiplex multiomics analysis can advance your research—from visualizing cellular responses in the brain to understanding how tissue architecture shapes disease progression.

Agenda

16:00 – Welcome & Introduction | Martin Schalén, Miltenyi Biotec Nordics
16:05 – Urmas Roostalu, Senior Department Manager 3D imaging, Gubra – Whole-Organ Light Sheet Microscopy in Drug Discovery: From Target Characterization to Mode-of-Action Studies
16:25 – Sophia Scheuermann, PhD student, University Children's Hospital Tübingen & Hopp Children's Cancer Center Heidelberg) – Unveiling the Tumor Microenvironment: A Roadmap to Precision Immunotherapy
16:45 – Daniel Schäfer, Group Leader Cellular Immunotherapy, R&D reagents, Miltenyi Biotec – Spatial biology helps to identify biomarkers for CAR T cell drug development
17:05 – Q&A & Roundtable Discussion
17:20 – Drinks, Refreshments & Networking

Featured Speakers & Topics

• Urmas Roostalu (Gubra) will highlight how 3D imaging reveals metabolic and drug effects in the brain at the cellular level, covering neuron-glia interactions, blood-brain barrier integrity, and drug distribution.
• Sophia Scheuermann (Eberhard Karls Universität Tübingen) will show how multiplex imaging guides precision immunotherapy.
• Daniel Schäfer (Miltenyi Biotec) will discuss identifying novel biomarkers for adenocarcinoma treatment.

This free event is open to scientists from academia and industry. Refreshments will be provided.

Please be advised that you are entering an area where you may be in a background of video, photo or audio recording. These recordings may be used and published for marketing and PR purposes. If you are the focus of the recording your explicit consent will be requested separately.

For general information on the use of your personal information by Miltenyi, please see Miltenyi’s Privacy Statement (www.miltenyibiotec.com/privacy).